Haleon plc (HLN)
$9.76 $0.03 (0.31%) 4:39 PM 12/14/24
NYSE | $USD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$43.72B -
Day's Range
$9.73 - $9.84 -
Volume
7,068,852 -
52 Week Low / High
$7.83 - $10.80 -
PE Ratio
28.44x -
PEG Ratio
1.72 -
Dividend Frequency
semi-annual
- 2
- Strong Buy
- 1
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $9.25
- Target Price
Company News
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
Pfizer offloads $3.3 billion stake in Sensodyne-maker Haleon — Oct 1st, 2024
(Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday. (Reporting by Prerna Bedi in Bengaluru; Editing by Savio D'Souza) View comment...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
Pfizer offloads $3.3 billion stake in Sensodyne-maker Haleon — Oct 1st, 2024
(Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday. (Reporting by Prerna Bedi in Bengaluru; Editing by Savio D'Souza) View comment...
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager — Oct 1st, 2024
MISSISSAUGA, ON, Oct. 1, 2024 /CNW/ - Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcicas General Manager, Haleon Canada. This appointment follows Rupa Bahri stepping down after a distinguished 13-year career with the company to pursue other...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
HLN or PODD: Which Is the Better Value Stock Right Now? — Oct 3rd, 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the bes...
-
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice — Oct 11th, 2024
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice On Friday, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business....
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon Canada Donates Children's Advil to Organizations in Need — Oct 9th, 2024
Ahead of cold and flu season, this donation helps put critical medicine in the hands of those who need it most. MISSISSAUGA, ON, Oct. 9, 2024 /CNW/ - Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian...
-
Haleon Backs Guidance Despite Revenue, Profit Miss — Oct 31st, 2024
Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Continue reading View comments...
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
-
Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company — Oct 10th, 2024
Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading actions The top 13 shareholders own 51% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a compa...
Portfolio
Comprised of 1 portfolios